Abstract
Antibodies (Abs) displaying an agonist or antagonist activity are powerful tools for mimicking or blocking physiological functions in the cell. A number of applications of Abs in diagnosis and therapy require multivalent reagents, either because biological activity depends on the polymeric nature of the antigen (Ag), or because biological activity depends on an effect on the formation of homodimeric species. Often dimerization is a prerequisite for activation of a number of surface receptors by their natural ligands and divalent Abs are typically required for mimicking or blocking the activity of such ligands.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Winter, G., Griffiths, A. D., Hawkins, R. E., and Hoogenboom, H. R. (1994) Making antibodies by phage display technology. Ann. Rev. Immunol. 123, 443–455.
Pack, P. and Pluckthun A. (1992) Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli. Biochemistry 31, 1579–1584.
Ito, W. and Kurosawa, Y. (1993) Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of Protein A. J. Biol. Chem. 268, 20668–20675.
Kipriyanov, S. M., Little, M., Kropshofer, H., Bretling, F., Gotter, S., and Dubel, S. (1996) Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. Protein Eng. 9, 203–211.
Zaccolo, M., Griffiths, A. D., Prospero, T. D., Winter, G., and Gherardi, E. (1997) Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells. Eur. J. Immunol. 27, 618–623.
Griffiths, A., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., et al. (1994) Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13, 3245–3260.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Zaccolo, M. (2002). Selection of Functional Antibodies on the Basis of Valency. In: O’Brien, P.M., Aitken, R. (eds) Antibody Phage Display. Methods in Molecular Biology™, vol 178. Humana Press. https://doi.org/10.1385/1-59259-240-6:255
Download citation
DOI: https://doi.org/10.1385/1-59259-240-6:255
Publisher Name: Humana Press
Print ISBN: 978-0-89603-906-3
Online ISBN: 978-1-59259-240-1
eBook Packages: Springer Protocols